The capsule that protects itself: the patented GELITA® RXL technology prevents crosslinking in soft gelatine capsules and thus increases shelf-life. Gelatine capsules are among the most popular dosage forms for drugs, OTC products and food supplements. However, certain types of reactive fillings may cause the gelatine in the capsule to react and crosslink. This is especially true under high temperature and humidity storage conditions. This leads to a lower solubility of the capsules, resulting in longer dissolution times in the gastrointestinal tract.  

To prevent crosslinking, GELITA has introduced a new line of pharmaceutical gelatine that significantly reduces the inter-molecular crosslinking of large gelatine molecules. GELITA® RXL is available from multiple manufacturing sites all around the world and can be sourced from a variety of raw materials.